Goldman Sachs Group Inc Anika Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 68,685 shares of ANIK stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,685
Previous 88,727 22.59%
Holding current value
$1.19 Million
Previous $2.19 Million 48.43%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$16.04 - $25.53 $321,473 - $511,672
-20,042 Reduced 22.59%
68,685 $1.13 Million
Q3 2024

Nov 14, 2024
BUY
$24.25 - $28.75 $336,347 - $398,762
13,870 Added 18.53%
88,727 $2.19 Million
Q2 2024

Aug 13, 2024
SELL
$24.57 - $28.47 $50,933 - $59,018
-2,073 Reduced 2.69%
74,857 $1.9 Million
Q1 2024

May 15, 2024
SELL
$21.95 - $26.42 $83,673 - $100,713
-3,812 Reduced 4.72%
76,930 $1.95 Million
Q4 2023

Feb 13, 2024
SELL
$18.47 - $23.3 $32,544 - $41,054
-1,762 Reduced 2.14%
80,742 $1.83 Million
Q3 2023

May 14, 2024
BUY
$16.98 - $26.1 $29,918 - $45,988
1,762 Added 2.18%
82,504 $1.54 Million
Q3 2023

Nov 14, 2023
BUY
$16.98 - $26.1 $377,176 - $579,759
22,213 Added 36.84%
82,504 $1.54 Million
Q2 2023

May 14, 2024
BUY
$25.16 - $28.86 $256,254 - $293,939
10,185 Added 20.33%
60,291 $1.57 Million
Q2 2023

Aug 14, 2023
BUY
$25.16 - $28.86 $256,254 - $293,939
10,185 Added 20.33%
60,291 $1.57 Million
Q1 2023

May 14, 2024
BUY
$25.91 - $32.1 $96,152 - $119,123
3,711 Added 8.0%
50,106 $1.44 Million
Q1 2023

May 11, 2023
BUY
$25.91 - $32.1 $96,152 - $119,123
3,711 Added 8.0%
50,106 $1.44 Million
Q4 2022

May 14, 2024
SELL
$23.85 - $31.91 $515,947 - $690,309
-21,633 Reduced 31.8%
46,395 $1.37 Million
Q4 2022

Feb 13, 2023
SELL
$23.85 - $31.91 $515,947 - $690,309
-21,633 Reduced 31.8%
46,395 $1.37 Million
Q3 2022

May 14, 2024
SELL
$21.74 - $24.68 $1.73 Million - $1.97 Million
-79,669 Reduced 53.94%
68,028 $1.62 Million
Q3 2022

Nov 10, 2022
SELL
$21.74 - $24.68 $1.73 Million - $1.97 Million
-79,669 Reduced 53.94%
68,028 $1.62 Million
Q2 2022

May 14, 2024
BUY
$20.4 - $25.53 $1.37 Million - $1.71 Million
66,955 Added 82.92%
147,697 $3.3 Million
Q2 2022

Aug 15, 2022
BUY
$20.4 - $25.53 $954,311 - $1.19 Million
46,780 Added 46.35%
147,697 $3.3 Million
Q1 2022

May 16, 2022
BUY
$24.7 - $36.54 $2.22 Million - $3.29 Million
90,029 Added 826.86%
100,917 $2.53 Million
Q4 2021

Feb 14, 2022
SELL
$35.83 - $45.03 $692,414 - $870,204
-19,325 Reduced 63.96%
10,888 $390,000
Q3 2021

Nov 10, 2021
BUY
$38.75 - $44.47 $1.17 Million - $1.34 Million
30,213 New
30,213 $1.29 Million

Others Institutions Holding ANIK

# of Institutions
111
Shares Held
11.1M
Call Options Held
1.8K
Put Options Held
1.9K
View Full List

About Anika Therapeutics, Inc.

ANIK Quotes by TradingView
  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $254M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email